ArticleFrontiers in cell and developmental biology2025
Investigating the metabolic reprogramming mechanisms in diabetic nephropathy: a comprehensive analysis using bioinformatics and machine learning.
Article in Frontiers in cell and developmental biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multifaceted mechanistic exploration ofFrontiers in cell and developmental biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diabetic nephropathy (DN) is a common complication of diabetes, characterized by damage to renal tubules and glomeruli, leading to progressive renal dysfunction. The aim of our study is to explore the key role of metabolic reprogramming (MR) in the pathogenesis of DN. Methods: In our study, three transcriptome datasets (GSE30528, GSE30529, and GSE96804) were sourced from the Gene Expression Omnibus (GEO) database. These datasets were integrated for batch effect correction and subsequently subjected to differential expression analysis to identify differentially expressed genes (DEGs) between DN and control samples. The identified DEGs were cross-referenced with genes associated with MR to derive MR associated differentially expressed genes (MRRDEGs). These MRRDEGs underwent Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses. To identify key genes and develop diagnostic models, four machine learning algorithms were employed in conjunction with weighted gene co-expression network analysis (WGCNA) and the protein interaction tool CytoHubba. Gene set enrichment analysis (GSEA) and CIBERSORT analysis were conducted on the key genes to assess immune cell infiltration in DN. Additionally, a competitive endogenous RNA (ceRNA) network was constructed using the key genes. Finally, the expression levels of core genes in human samples were validated through quantitative real-time PCR (qRT-PCR). Results: We identified 256 MRRDEGs, highlighting metabolic and inflammatory pathways in DN. KEGG analysis linked these genes to the MAPK signaling pathway, suggesting its key role in DN. Six key genes were pinpointed using WGCNA, PPI, and machine learning, with their diagnostic value confirmed by ROC analysis. CIBERSORT revealed a strong link between these genes and immune cell infiltration, indicating the immune response's role in DN. GSEA showed these genes' involvement in inflammatory and metabolic processes. A ceRNA network was predicted to clarify gene regulation. qRT-PCR confirmed the expression patterns of Conclusion: Through bioinformatics analysis, a total of six potential MRRDEGs were identified, among which
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.